We use cookies to help provide and enhance our service and tailor content and advertisements. Disable them / read more. By continuing or closing this message you agree to the use of cookies.
-
The call for a merger moratorium due to the novel coronavirus pandemic likely won’t become law. -
Pity the EU merger officials whose work sets them the near-impossible task of predicting how the world economy will look after Covid-19. -
Companies charged with breaking EU merger procedures may get fine reductions if they agree to cooperate with investigators. -
Ecolab and Holchem's merger block by the UK competition regulator has exposed frictions over its use of customer surveys. -
AbbVie’s $63 million merger with Allergan is well-positioned for unconditional antitrust clearance in Brazil, MLex has learned. -
Activist investor Jana Partners reduced its stake in Jack in the Box by almost half, according to a securities filing today. -
Curaleaf aims to create the US’s biggest cannabis company with its $875 million GrassRoots merger. -
Abbvie has withdrawn the antitrust paperwork for its $63 billion purchase of Allergan with the US Federal Trade Commission, MLex has learned. -
China's approach to a couple of US-linked transactions in 2020 is set to answer some persistent questions on the country's merger control. -
Struggling healthcare providers often view consolidation as the only means of shouldering the ever-skyrocketing cost of care.